The Future of CAR T Cell Therapy
Kilder
- Statnews: Uncertainty in CRISPR world and the start of more M&A - statnews.com
- Statnews: Merus drug, with immunotherapy, shows preliminary survival boost for patients with head and neck cancer - statnews.com
- Fiercebiotech: Candel sheds more light on successful late-stage trial of prostate cancer immunotherapy - Fierce Biotech
- Biopharmadive: Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer - BioPharma Dive
- Biospace: FDA approves Roche’s Susvimo for diabetic retinopathy - BioSpace
- Nature: Cell trajectory modulation: rapid microfluidic biophysical profiling of CAR T cell functional phenotypes - Nature
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.